30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
Sweden Pharmaceuticals

Oncozenge AB (ONCOZ)

Track

The most recent insider trading activity occurred on November 28, 2025, with the Chief Executive Officer, Stian Kildal, purchasing shares valued at $397,494.7. Prior to this, Mr. Kildal made several other purchases throughout 2025. Niclas Holmgren, a Board Member, also made purchases in November 2024. All recorded transactions are buy orders.
Stock chart
Ticker: ONCOZ Exchange: STO
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Stian Kildal
Chief Executive Officer (CEO)/Managing Directory
1 purchase — total 397,495 SEK
Buy 28 Nov 2025
Value SEK1,636,848.31 | Price 234.83 | Shares 34,498
Buy 9 Sep 2025
Value SEK4,038,650.84 | Price 163.89 | Shares 57,884
Buy 26 Aug 2025
Value SEK173,506.94 | Price 6.94 | Shares 25,001
Buy 25 Jun 2025
Value SEK142,500.00 | Price 5.70 | Shares 25,000
Buy 7 Apr 2025
Value SEK85,026.24 | Price 4.16 | Shares 20,439
Buy 28 Mar 2025
Value SEK118,200.00 | Price 5.91 | Shares 20,000
Buy 28 Mar 2025
Value SEK118,200.00 | Price 5.91 | Shares 20,000
Buy 21 Nov 2024
Value SEK199,921.55 | Price 3.53 | Shares 56,635
Buy 18 Nov 2024
Value SEK316,800.00 | Price 10.56 | Shares 30,000
Buy 9 Jan 2024
Value SEK79,000.00 | Price 3.16 | Shares 25,000
Buy 15 Nov 2023
Value SEK69,650.00 | Price 2.79 | Shares 25,000
Buy 21 Sep 2023
Value SEK124,000.00 | Price 3.10 | Shares 40,000
Buy 20 Sep 2023
Value SEK174,600.00 | Price 2.91 | Shares 60,000
Buy 8 Mar 2021
Value SEK108,988.25 | Price 10.25 | Shares 10,633
Buy 8 Mar 2021
Value SEK108,988.25 | Price 10.25 | Shares 10,633
Buy 8 Mar 2021
Value SEK100,009.25 | Price 10.25 | Shares 9,757
Buy 5 Mar 2021
Value SEK205,000.00 | Price 10.25 | Shares 20,000
Buy 5 Mar 2021
Value SEK205,000.00 | Price 10.25 | Shares 20,000
Buy 5 Mar 2021
Value SEK154,429.00 | Price 11.11 | Shares 13,900
Buy 5 Mar 2021
Value SEK150,008.75 | Price 10.25 | Shares 14,635
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-28 2025-11-28 B Purchase
3.5
Stian Kildal

Chief Executive Officer (CEO)/Managing Directory

Officer
34,498
234.83
SEK1,636,848 		34,498 234.83 SEK1,636,848
2025-09-09 2025-09-09 B Purchase
3.5
Stian Kildal

Chief Executive Officer (CEO)/Managing Directory

Officer
57,884
163.89
SEK4,038,651 		57,884 163.89 SEK4,038,651
2025-08-26 2025-08-26 B Purchase
3.5
Stian Kildal

Chief Executive Officer (CEO)/Managing Directory

Officer
1,406
319.74
SEK1,425,987 		1,406 319.74 SEK1,425,987
2025-06-25 2025-06-25 B Purchase
3.5
Stian Kildal

Chief Executive Officer (CEO)/Managing Directory

Officer
25,000
5.70
SEK142,500 		25,000 5.70 SEK142,500
2025-04-07 2025-04-07 B Purchase
3.5
Stian Kildal

Chief Executive Officer (CEO)/Managing Directory

Officer
20,439
4.16
SEK85,026 		20,439 4.16 SEK85,026
2025-03-29 2025-03-28 B Purchase
3.5
Stian Kildal

Chief Executive Officer (CEO)/Managing Directory

Officer
20,000
5.91
SEK118,200 		20,000 5.91 SEK118,200
2025-03-28 2025-03-28 B Purchase
3.5
Stian Kildal

Chief Executive Officer (CEO)/Managing Directory

Officer
20,000
5.91
SEK118,200 		20,000 5.91 SEK118,200
2024-11-21 2024-11-21 B Purchase
1.8
Niclas Holmgren

Member of the Board of Directors

Director
56,635
3.53
SEK199,922 		56,635 3.53 SEK199,922
2024-11-18 2024-11-18 B Purchase
1.8
Niclas Holmgren

Member of the Board of Directors

Director
30,000
10.56
SEK316,800 		30,000 10.56 SEK316,800
2024-01-10 2024-01-09 B Purchase
3.5
Stian Kildal

Chief Executive Officer (CEO)/Managing Directory

Officer
25,000
3.16
SEK79,000 		25,000 3.16 SEK79,000
2023-11-15 2023-11-15 B Purchase
3.5
Stian Kildal

Chief Executive Officer (CEO)/Managing Directory

Officer
25,000
2.79
SEK69,650 		25,000 2.79 SEK69,650
2023-09-21 2023-09-21 B Purchase
3.5
Stian Kildal

Chief Executive Officer (CEO)/Managing Directory

Officer
40,000
3.10
SEK124,000 		40,000 3.10 SEK124,000
2023-09-21 2023-09-20 B Purchase
3.5
Stian Kildal

Chief Executive Officer (CEO)/Managing Directory

Officer
60,000
2.91
SEK174,600 		60,000 2.91 SEK174,600
2021-03-09 2021-03-08 B Purchase
2.8
Torben Mogensen

Member of the Board of Directors

Director
10,633
10.25
SEK108,988 		10,633 10.25 SEK108,988
2021-03-08 2021-03-08 B Purchase
2.5
Anna Helena Constance Ljung

Chairman of the Board of Directors

Director
9,757
10.25
SEK100,009 		9,757 10.25 SEK100,009
2021-03-08 2021-03-08 B Purchase
2.8
Torben Mogensen

Member of the Board of Directors

Director
10,633
10.25
SEK108,988 		10,633 10.25 SEK108,988
2021-03-08 2021-03-05 B Purchase
1.4
Cindy Wong

Other member of the company's administrative, management or supervisory body
20,000
10.25
SEK205,000 		20,000 10.25 SEK205,000
2021-03-08 2021-03-05 B Purchase
1.0
Pirkko Vilja Päivikki Sulila Tamsen

Chief Executive Officer (CEO)/Managing Directory

Officer
20,000
10.25
SEK205,000 		20,000 10.25 SEK205,000
2021-03-08 2021-03-05 B Purchase
1.0
Pirkko Vilja Päivikki Sulila Tamsen

Chief Executive Officer (CEO)/Managing Directory

Officer
13,900
11.11
SEK154,429 		13,900 11.11 SEK154,429
2021-03-08 2021-03-05 B Purchase
Hilde Furberg

Member of the Board of Directors

Director
14,635
10.25
SEK150,009 		14,635 10.25 SEK150,009
Explore more

More insider trading research around Oncozenge AB

More insider trades in Sweden
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in Europe